IRIS
BUCOLO, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.040
EU - Europa 4.893
AS - Asia 4.017
SA - Sud America 830
AF - Africa 493
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 19.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.678
SG - Singapore 1.942
IT - Italia 1.892
CN - Cina 1.518
IE - Irlanda 1.043
UA - Ucraina 852
BR - Brasile 761
CA - Canada 314
CI - Costa d'Avorio 272
RU - Federazione Russa 266
DE - Germania 251
KR - Corea 158
SN - Senegal 144
SE - Svezia 109
GB - Regno Unito 98
IN - India 84
FI - Finlandia 79
VN - Vietnam 59
FR - Francia 49
CH - Svizzera 44
NL - Olanda 37
BD - Bangladesh 34
PL - Polonia 34
JP - Giappone 30
UZ - Uzbekistan 30
BE - Belgio 27
ES - Italia 26
MX - Messico 26
IQ - Iraq 24
HK - Hong Kong 23
TR - Turchia 23
AR - Argentina 20
NG - Nigeria 19
GR - Grecia 18
MA - Marocco 18
AT - Austria 17
ZA - Sudafrica 16
EC - Ecuador 13
CO - Colombia 12
LB - Libano 12
PK - Pakistan 12
AU - Australia 11
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
EU - Europa 9
ID - Indonesia 8
LT - Lituania 8
HN - Honduras 7
JO - Giordania 7
KE - Kenya 7
TN - Tunisia 7
VE - Venezuela 7
HR - Croazia 6
IL - Israele 6
IR - Iran 6
JM - Giamaica 5
PY - Paraguay 5
RO - Romania 5
AZ - Azerbaigian 4
EG - Egitto 4
NP - Nepal 4
PE - Perù 4
UY - Uruguay 4
BG - Bulgaria 3
DK - Danimarca 3
DZ - Algeria 3
KZ - Kazakistan 3
MK - Macedonia 3
OM - Oman 3
PT - Portogallo 3
SA - Arabia Saudita 3
TW - Taiwan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CL - Cile 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
LK - Sri Lanka 1
MC - Monaco 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
Totale 19.291
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.508
Chandler 1.172
Singapore 1.142
Dublin 1.036
Jacksonville 867
Catania 579
Chicago 540
Boardman 447
Hefei 354
Nanjing 286
Lawrence 280
Cambridge 274
Abidjan 272
Andover 271
Ashburn 269
Houston 244
Toronto 228
Dallas 206
Beijing 175
Seoul 155
Des Moines 146
Dakar 144
San Mateo 127
Wilmington 120
Civitanova Marche 102
Los Angeles 86
Grafing 83
Nanchang 77
Florence 76
Shenyang 69
Ottawa 67
Saint Petersburg 66
Hebei 64
Rome 61
The Dalles 61
São Paulo 59
Council Bluffs 56
Jiaxing 56
Bremen 55
Columbus 53
Messina 48
Changsha 47
Palermo 47
Tianjin 46
Munich 37
New York 32
Seattle 32
Redwood City 31
Belo Horizonte 30
Milan 30
Moscow 28
Brooklyn 27
Dong Ket 27
Falls Church 27
Rio de Janeiro 27
San Francisco 27
Aci Catena 26
Tokyo 26
Dearborn 25
Helsinki 25
Lappeenranta 24
Naples 23
Pune 23
Warsaw 23
Washington 23
Turku 22
Brussels 21
Hangzhou 21
Ningbo 20
Pozzallo 20
Abuja 18
Guangzhou 18
Jinan 18
Liberty Lake 18
Norwalk 18
Zhengzhou 18
Curitiba 17
Hong Kong 16
London 16
Phoenix 16
Belpasso 15
Brasília 15
Lissone 15
Shanghai 15
Boston 14
Bronte 14
Den Haag 14
Tashkent 14
Padova 13
Hanoi 12
Hyderabad 12
Redmond 12
Stockholm 12
Turin 12
Baghdad 11
Boydton 11
Johannesburg 11
Mascalucia 11
Mumbai 11
Paternò 11
Totale 13.226
Salva come PNG Salva come JPEG
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 192
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 180
Current drug treatments targeting dopamine D3 receptor 178
Dopaminergic-GABAergic interplay and alcohol binge drinking 162
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 161
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 148
Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia 130
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 128
Antioxidant and osmoprotecting activity of taurine in dry eye models 123
Design, Synthesis and Antiinflammatory Activity of Novel g-Tocopherol Acetylsalicylic acid Ester Codrug 122
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 122
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 118
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 114
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 112
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 109
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition 108
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 107
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 106
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 105
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 104
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 103
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 101
Caffeine Protects Against Retinal Inflammation 101
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 99
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 99
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 99
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 99
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 98
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 98
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 98
Prognostic significance of deregulated microRNAs in uveal melanomas 97
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 97
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 96
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 95
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 94
P2X7 receptor antagonism: implications in diabetic retinopathy 91
Ruolo fisiologico del monossido d’azoto e monossido di carbonio nella modulazione della pressione endoculare 88
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 88
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina 87
Rapid determination of nimesulide in rabbit aqueous humor by liquid chromatography 85
Acidic mammalian chitinase in dry eye conditions 85
Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies 84
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 83
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 83
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 83
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 82
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 82
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 81
Fluoxetine Protects Retinal Ischemic Damage in Mice 81
Carnosol attenuates high glucose damage in human retinal endothelial cells through regulation of ERK/Nrf2/HO-1 pathway 80
Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells 80
Controversies in Glaucoma: Current Medical Treatment and Drug Development 80
Farmacologia Oculare 80
Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model 79
LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes 79
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 79
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 79
Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma 78
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 78
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 78
L'acido Ialuronico come Carrier Ideale nella Veicolazione Topica Oculare del Timololo 78
Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model 78
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 78
In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease 77
Valutazione del tempo di bioerosione di inserti intravitreali a base di esteri dell'acido ialuronico 77
A prolonged release polymeric nanocarrier for ocular administration 77
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 76
Protective effects of a coumarin derivative in diabetic rats 76
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 76
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 76
Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes 76
Retinal protection and distribution of curcumin in vitro and in vivo 76
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 76
Modulation of pro-oxidant and pro-inflammatory activities of m1 macrophages by the natural dipeptide carnosine 76
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 75
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review 74
Ocular pharmacokinetics profile of different indomethacin topical formulations. 73
Methylprednisolone delivery by Hyalobend corneal shields and its effects on rabbit ocular inflammation 73
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 73
Evaluation of tolerability of a series of lipoamino acids using biological membranes and a biomembrane model 73
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. 73
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 72
Dopamine-3 receptor modulates intraocular pressure: implications for glaucoma 72
Enhanced ocular anti-inflammatory activity of lbuprofen carried by an Eudragit RS100((R)) nanoparticle suspension 72
Effect of sodium naproxen on inflammatory response induced by anterior chamber paracentesis in the rabbit 72
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 71
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 71
Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits 71
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 71
Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death 71
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 71
Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells 70
Lipoprotein(a) serum levels in diabetic patients with retinopathy 70
Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients 70
COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, OR AMELIORATING OCULAR INFLAMMATORY WITH LOWER RISK OF INCREASED INTRAOCULAR PRESSURE 70
Novel therapeutics in glaucoma management 70
Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats 70
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 69
Effects of hyaluronan on free-radical formation, corneal endothelium damage, and inflammation parameters after phacoemulsification in rabbits 69
Carbon monoxide and the eye: Implications for glaucoma therapy 69
Totale 9.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.438 0 0 183 15 429 53 210 10 213 43 188 94
2021/20222.188 245 281 44 34 310 65 323 96 211 38 71 470
2022/20233.708 321 177 55 378 398 605 37 627 869 46 131 64
2023/20241.604 118 233 87 107 83 330 27 119 12 25 279 184
2024/20256.523 82 1.011 334 322 1.357 733 330 277 560 581 470 466
2025/20261.597 819 738 40 0 0 0 0 0 0 0 0 0
Totale 19.876